(Q36528732)

14 August 2017

1 reference

title

Transdermal treatment options for neurological disorders: impact on the elderly (English)

1 reference

14 August 2017

Lorenzo Priano

1

1 reference

14 August 2017

Maria Rosa Gasco

series ordinal

2

1 reference

14 August 2017

Alessandro Mauro

series ordinal

3

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

23

1 reference

14 August 2017

issue

5

1 reference

14 August 2017

page(s)

357-375

1 reference

Transdermal nicotine in PD: a randomized, double-blind, placebo-controlled study

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623050-00001

An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623050-00001

Gastric emptying in Parkinson's disease: patients with and without response fluctuations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623050-00001

COMT inhibition: a new treatment strategy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623050-00001

Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO in MPTP-treated squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623050-00001

Intranasal apomorphine in parkinsonian on-off fluctuations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623050-00001

Long-term administration of oral physostigmine in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623050-00001

Biological and neuropsychological characterization of physostigmine responders and nonresponders in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623050-00001

Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623050-00001

Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623050-00001

Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623050-00001

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623050-00001

Topical ketamine treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623050-00001

Iontophoretic delivery of apomorphine. I: In vitro optimization and validation.

21 January 2018

1 reference

12 December 2020

Pharmacokinetic characterisation of transdermal delivery systems

1 reference

12 December 2020

The antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+PHNO): preliminary results

1 reference

12 December 2020

Continuous transdermal dopaminergic stimulation in advanced Parkinson's disease.

1 reference

12 December 2020

Plasma physostigmine concentrations after controlled-release oral administration.

1 reference

12 December 2020

Gastric emptying time and gastric motility in patients with Parkinson's disease

1 reference

12 December 2020

A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease

1 reference

12 December 2020

Potential of transdermal drug delivery in Parkinson's disease

1 reference

12 December 2020

Transdermal estrogen patches for aggressive behavior in male patients with dementia: a randomized, controlled trial

1 reference

12 December 2020

Molecular basis of levodopa-induced dyskinesias.

1 reference

12 December 2020

Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease

1 reference

12 December 2020

Parkinson's disease monotherapy with controlled-release MK-458 (PHNO): double-blind study and comparison to carbidopa/levodopa

1 reference

12 December 2020

Modulation of working, short- and long-term memory by nicotinic receptors in the basolateral amygdala in rats

1 reference

12 December 2020

Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease

1 reference

12 December 2020

Transdermal therapeutic fentanyl-system (TTS-F).

1 reference

12 December 2020

Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain

1 reference

12 December 2020

Apomorphine infusion and the long-duration response to levodopa in advanced Parkinson's disease.

1 reference

12 December 2020

Presynaptic nicotinic receptors modulating dopamine release in the rat striatum

1 reference

12 December 2020

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

12 December 2020

Transdermal administration of bromocriptine

1 reference

12 December 2020

Transdermal permeation of apomorphine through hairless mouse skin from microemulsions

1 reference

12 December 2020

Pharmacokinetics of apomorphine in Parkinson's disease.

1 reference

12 December 2020

Topical ketamine gel: possible role in treating neuropathic pain

1 reference

12 December 2020

Absorption, metabolism, and disposition of [14C]SDZ ENA 713, an acetylcholinesterase inhibitor, in minipigs following oral, intravenous, and dermal administration

1 reference

12 December 2020

Vaginal bromocriptine: pharmacology and effect on serum prolactin in normal women

1 reference

12 December 2020

Recent advances in drug delivery technology for neurology

1 reference

12 December 2020

The effects of nicotine in dermal plaster on cognitive functions in patients with Alzheimer's disease.

1 reference

12 December 2020

The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease.

1 reference

12 December 2020

Iontophoretic delivery of apomorphine. II: An in vivo study in patients with Parkinson's disease.

1 reference

12 December 2020

Motor response to levodopa in patients with parkinsonian motor fluctuations: a follow-up study over three years

1 reference

12 December 2020

Transdermal buprenorphine for treating nociceptive and neuropathic pain: four case studies

1 reference

12 December 2020

Transdermal nicotine for agitation in dementia

1 reference

12 December 2020

A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease.

1 reference

12 December 2020

Transdermal rivastigmine treatment does not worsen impaired performance of complex motions in patients with Alzheimer's disease

1 reference

12 December 2020

Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neurons

1 reference

12 December 2020

Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature

1 reference

12 December 2020

Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration

1 reference

12 December 2020

Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease

1 reference

12 December 2020

Protein redistribution diet restores motor function in patients with dopa-resistant "off" periods

1 reference

12 December 2020

Apomorphine: an underutilized therapy for Parkinson's disease

1 reference

12 December 2020

Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety

1 reference

12 December 2020

Transdermal apomorphine permeation from microemulsions: a new treatment in Parkinson's disease

1 reference

12 December 2020

Clinical studies with transdermal rotigotine in early Parkinson's disease

1 reference

12 December 2020

Transdermal lisuride: short-term efficacy and tolerability study in patients with severe restless legs syndrome

1 reference

12 December 2020

Bromocriptine long acting (LA) 50 mg intramuscular (IM) for the on-off phenomenon in Parkinson's disease

1 reference

12 December 2020

Potential role for estrogen replacement in the treatment of Alzheimer's dementia

1 reference

12 December 2020

Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.

1 reference

12 December 2020

Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice

1 reference

12 December 2020

Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.

1 reference

12 December 2020

The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas

1 reference

12 December 2020

Levodopa and the progression of Parkinson's disease

1 reference

12 December 2020

Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmoset

1 reference

12 December 2020

Controlled transdermal iontophoresis by ion-exchange fiber.

1 reference

12 December 2020

Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease

1 reference

12 December 2020

Future delivery systems for apomorphine in patients with Parkinson's disease.

1 reference

12 December 2020

NMDA systems in the amygdala and piriform cortex and nicotinic effects on memory function

1 reference

12 December 2020

Brain proton magnetic resonance spectroscopy in Alzheimer disease: changes after treatment with xanomeline

1 reference

12 December 2020

A promising new technology for Parkinson's disease

1 reference

12 December 2020

Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance

1 reference

12 December 2020

Circadian variation of the effects of immobility on symptoms of restless legs syndrome

1 reference

12 December 2020

The effects of nicotine on Parkinson's disease

1 reference

12 December 2020

A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease

1 reference

12 December 2020

Iontophoretic administration of S(+)-ketamine in patients with intractable central pain: a placebo-controlled trial

1 reference

12 December 2020

Double-blind, randomized, placebo-controlled clinical trial on the efficacy and tolerability of a physostigmine patch in patients with senile dementia of the Alzheimer type.

1 reference

12 December 2020

Safety, tolerability, and efficacy of continuous transdermal dopaminergic stimulation with rotigotine patch in early-stage idiopathic Parkinson disease

1 reference

12 December 2020

Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group I

1 reference

12 December 2020

Long-term outpatient treatment of senile dementia with oral physostigmine

1 reference

12 December 2020

"Autocannibalism" of choline-containing membrane phospholipids in the pathogenesis of Alzheimer's disease-A hypothesis.

1 reference

12 December 2020

Transdermal lisuride delivery in the treatment of Parkinson's disease.

1 reference

12 December 2020

Selective full dopamine D1-like (SKF-82958) and D2-like (N-0923) agonist combination in the MPTP monkey model of hemiparkinsonism

1 reference

12 December 2020

Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositories

1 reference

12 December 2020

Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease

1 reference

12 December 2020

Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding

1 reference

12 December 2020

Clinical pharmacokinetics of anti-parkinsonian drugs

1 reference

12 December 2020

Continuous dopamine-receptor stimulation in advanced Parkinson's disease

1 reference

12 December 2020

Rectal apomorphine in Parkinson's disease

1 reference

12 December 2020

Role of dopamine receptor agonists in the treatment of restless legs syndrome

1 reference

12 December 2020

Physostigmine for Alzheimer's disease

1 reference

12 December 2020

Short- and long-duration responses to levodopa during the first year of levodopa therapy.

1 reference

12 December 2020

Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG.

1 reference

12 December 2020

Striatal molecular mechanisms and motor dysfunction in Parkinson's disease.

1 reference

12 December 2020

Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment

1 reference

12 December 2020

Transdermal buprenorphine in the treatment of chronic pain

1 reference

12 December 2020

Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease.

1 reference

12 December 2020

Use of apomorphine in clinical practice

1 reference

12 December 2020

Long-term management of noncancer pain with transdermal therapeutic system-fentanyl

1 reference

12 December 2020

Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO].

1 reference

12 December 2020

Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia

1 reference

12 December 2020

Nicotine for the treatment of Tourette's syndrome

1 reference

12 December 2020

Hormonal replacement therapy and Alzheimer's disease. All quiet on the western front?

1 reference

12 December 2020

Transdermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment

1 reference

12 December 2020

Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease

1 reference

12 December 2020

Effects of transdermal nicotine on learning, memory, verbal fluency, concentration, and general health in a healthy sample at risk for dementia

1 reference

12 December 2020

17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study

1 reference

12 December 2020

Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides

1 reference

12 December 2020

More than 7 years of consistent neuropathic pain relief in geriatric patients

1 reference

12 December 2020

In vivo mapping of brain cholinergic function in Parkinson's disease and progressive supranuclear palsy.

1 reference

12 December 2020

Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease

1 reference

12 December 2020

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

1 reference

12 December 2020

Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease.

1 reference

12 December 2020

Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study

1 reference

12 December 2020

The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale.

1 reference

12 December 2020

Relations between movement and single cell discharge in the substantia nigra of the behaving monkey

1 reference

12 December 2020

Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale

1 reference

12 December 2020

Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial

1 reference

12 December 2020

Stepwise intravenous infusion of apomorphine to determine the therapeutic window in patients with Parkinson's disease

1 reference

12 December 2020

Potential pharmacotherapy of Alzheimer disease. A comparison of various forms of physostigmine administration.

1 reference

12 December 2020

N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease

1 reference

12 December 2020

Transdermal application of steroid hormones for contraception.

1 reference

12 December 2020

10.2165/00002512-200623050-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

1033334512

0 references

1 reference